Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary-Jane Guerry

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|December 6, 2011
[Acute renal failure. Anuria]Mary-Jane Guerry, Mercé Jourdain
BMJ (Clinical Research Ed.)|August 8, 2012
Acute skin failureMary-Jane Guerry, Malcolm Lemyze
Kidney International|May 17, 2016
Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathyMary-Jane Guerry, Philippe Vanhille, Pierre Ronco, et al.
The European Respiratory Journal|December 4, 2012
Obesity supine death syndrome revisitedMalcolm Lemyze, Mary-Jane Guerry, Jihad Mallat, et al.
Infectious Disorders Drug Targets|June 18, 2011
New methods to clean ICU roomsCaroline Blazejewski, Mary-Jane Guerry, Sébastien Preau, et al.
Journal of Medical Case Reports|July 5, 2011
Fulminant hemophagocytic lymphohistiocytosis induced by pandemic A (H1N1) influenza: a case reportChristophe Willekens, Aurélie Cornelius, Mary-Jane Guerry, et al.
Shock (Augusta, Ga.)|September 21, 2013
Activated protein C improves macrovascular and microvascular reactivity in human severe sepsis and septic shockRaphaël Favory, Julien Poissy, Isabelle Alves, et al.
Annals of Intensive Care|April 17, 2013
Adverse events during intrahospital transport of critically ill patients: incidence and risk factorsErika Parmentier-Decrucq, Julien Poissy, Raphaël Favory, et al.
Arthritis and Rheumatism|June 26, 2012
Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitisRona M Smith, Rachel B Jones, Mary-Jane Guerry, et al.
BMC Musculoskeletal Disorders|June 3, 2014
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune diseaseHelena Marco, Rona M Smith, Rachel B Jones, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|December 6, 2011
[Acute renal failure. Anuria]Mary-Jane Guerry, Mercé Jourdain
BMJ (Clinical Research Ed.)|August 8, 2012
Acute skin failureMary-Jane Guerry, Malcolm Lemyze
Kidney International|May 17, 2016
Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathyMary-Jane Guerry, Philippe Vanhille, Pierre Ronco, et al.
The European Respiratory Journal|December 4, 2012
Obesity supine death syndrome revisitedMalcolm Lemyze, Mary-Jane Guerry, Jihad Mallat, et al.
Infectious Disorders Drug Targets|June 18, 2011
New methods to clean ICU roomsCaroline Blazejewski, Mary-Jane Guerry, Sébastien Preau, et al.
Journal of Medical Case Reports|July 5, 2011
Fulminant hemophagocytic lymphohistiocytosis induced by pandemic A (H1N1) influenza: a case reportChristophe Willekens, Aurélie Cornelius, Mary-Jane Guerry, et al.
Shock (Augusta, Ga.)|September 21, 2013
Activated protein C improves macrovascular and microvascular reactivity in human severe sepsis and septic shockRaphaël Favory, Julien Poissy, Isabelle Alves, et al.
Annals of Intensive Care|April 17, 2013
Adverse events during intrahospital transport of critically ill patients: incidence and risk factorsErika Parmentier-Decrucq, Julien Poissy, Raphaël Favory, et al.
Arthritis and Rheumatism|June 26, 2012
Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitisRona M Smith, Rachel B Jones, Mary-Jane Guerry, et al.
BMC Musculoskeletal Disorders|June 3, 2014
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune diseaseHelena Marco, Rona M Smith, Rachel B Jones, et al.
Pageof 2